Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AACR, acalabrutinib, accommodate, AOI, arm, AstraZeneca, ASU, background, Bendell, Carolina, Cary, chlorambucil, chlorambucilreported, Classification, Condensed, Daruka, FBIO, fixed, FOLFOX, forour, forty, furnish, Gemcitabine, GI, graph, herewith, ICML, identification, incentivize, index, Internet, JAK, JAKAFI, Johanna, Kingsport, knowncontractual, longest, Mahadevan, manuscript, maximizing, minimum, noncurrent, North, ofapproximately, onset, overhead, owner, PA, Pembrolizumab, Philadelphia, Polycythemia, portfolio, refractor, reinvestment, retrospective, ruxolitinib, solid, Tennessee, Topic, transaminase, transition, venetoclax, Vera, weincurred, West, withobinutuzumab
Filing tables
Filing exhibits
Related press release
TGTX similar filings
Filing view
External links